CO5690544A2 - Derivados de acido alcanoico sustituido con cicloalquilo metodos para su produccion y su uso como medicamentos - Google Patents
Derivados de acido alcanoico sustituido con cicloalquilo metodos para su produccion y su uso como medicamentosInfo
- Publication number
- CO5690544A2 CO5690544A2 CO05085507A CO05085507A CO5690544A2 CO 5690544 A2 CO5690544 A2 CO 5690544A2 CO 05085507 A CO05085507 A CO 05085507A CO 05085507 A CO05085507 A CO 05085507A CO 5690544 A2 CO5690544 A2 CO 5690544A2
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- cycloalkyl
- medications
- derivatives
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/06—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton
- C07C275/10—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an acyclic and saturated carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C275/24—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/26—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Ophthalmology & Optometry (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Virology (AREA)
Abstract
1.- Un compuesto de la fórmula Ien la que el anillo A es cicloalcanodiilo (C3-C8) o cicloalquenodiilo(C3-C8), donde en los anillos cicloalcano- o cicloalquenodiilo uno o más átomos de carbono pueden estar reemplazados por átomos de oxígeno;R1 y R2, independientemente entre sí, son H, alquilo (C1-C6), cicloalquilo (C3-C8) o arilo (C6-C10);R3 es cicloalquilo (C3-C6) o alquilo (C1-C12), que están opcionalmente sustituidos con arilo (C6-C10), heteroarilo (C5-C6) o cicloalquilo (C3-C6), donde arilo, heteroarilo o cicloalquilo por su parte, pueden estar sustituidos con alquilo (C1-C6), alcoxi (C1-C6), CI, Br, I, CO-alquilo (C1-C6), CO-O-alquilo (C1-C6), CO-NH-alquilo (C1-C6) o CO-N(alquilo (C1-C6))2;X es alcanodiilo (C1-C6), donde en el grupo alcanodiilo uno o más átomos de carbono pueden reemplazarse por átomos de oxígeno;Y1 es CO o un enlace;Y2 es NH, alcanodiilo (C1-C12), donde en el grupo alcanodiilo uno o más átomos de carbono pueden reemplazarse por átomos de oxígeno;R4 es alquilo (C1-C8);R5 es H, alquilo (C1-C6);R6 es H;y sus sales fisiológicamente aceptables.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10308356A DE10308356A1 (de) | 2003-02-27 | 2003-02-27 | Cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5690544A2 true CO5690544A2 (es) | 2006-10-31 |
Family
ID=32841933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO05085507A CO5690544A2 (es) | 2003-02-27 | 2005-08-26 | Derivados de acido alcanoico sustituido con cicloalquilo metodos para su produccion y su uso como medicamentos |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1599443B1 (es) |
JP (1) | JP2006519200A (es) |
KR (1) | KR20050115255A (es) |
CN (1) | CN100469761C (es) |
AR (1) | AR043431A1 (es) |
AT (1) | ATE538086T1 (es) |
BR (1) | BRPI0407871A (es) |
CA (1) | CA2516633A1 (es) |
CO (1) | CO5690544A2 (es) |
DE (1) | DE10308356A1 (es) |
HR (1) | HRP20050739A2 (es) |
IL (1) | IL170315A (es) |
MA (1) | MA27743A1 (es) |
MX (1) | MXPA05008990A (es) |
NO (1) | NO20054389L (es) |
PA (1) | PA8596701A1 (es) |
PE (1) | PE20040958A1 (es) |
PL (1) | PL377755A1 (es) |
RU (1) | RU2005129998A (es) |
TW (1) | TW200505830A (es) |
WO (1) | WO2004076401A1 (es) |
ZA (1) | ZA200505766B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1942898T5 (pl) | 2005-09-14 | 2014-10-31 | Takeda Pharmaceuticals Co | Inhibitory peptydazy dipeptydylowej do leczenia cukrzycy |
CN102675221A (zh) | 2005-09-16 | 2012-09-19 | 武田药品工业株式会社 | 用于制备嘧啶二酮衍生物的方法中的中间体 |
CA2624102A1 (en) | 2005-09-29 | 2007-04-12 | Sanofi-Aventis | Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
WO2007112347A1 (en) | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE61716B1 (en) * | 1987-06-02 | 1994-11-30 | Warner Lambert Co | Antihyperlipidemic and antiatherosclerotic urea compounds |
US5420164A (en) * | 1991-04-04 | 1995-05-30 | Yoshitomi Pharmaceutical Industries, Ltd. | Cycloalkylurea compounds |
GB9606805D0 (en) * | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
US6057338A (en) * | 1997-04-04 | 2000-05-02 | Merck & Co., Inc. | Somatostatin agonists |
BR9811988A (pt) * | 1997-08-22 | 2000-09-05 | Hoffmann La Roche | Derivados de n-alcanoilfenilalanina |
WO1999022735A1 (en) * | 1997-10-30 | 1999-05-14 | Merck & Co., Inc. | Somatostatin agonists |
JP2002201171A (ja) * | 2000-10-27 | 2002-07-16 | Toa Eiyo Ltd | ウレアカルボン酸誘導体 |
JP2002201127A (ja) * | 2000-12-28 | 2002-07-16 | Pola Chem Ind Inc | ウレア誘導体 |
BR0207227A (pt) * | 2001-02-15 | 2004-02-10 | Pfizer Prod Inc | Compostos receptores ativados proliferadores ppar |
-
2003
- 2003-02-27 DE DE10308356A patent/DE10308356A1/de not_active Withdrawn
-
2004
- 2004-02-19 CA CA002516633A patent/CA2516633A1/en not_active Abandoned
- 2004-02-19 EP EP04712498A patent/EP1599443B1/de not_active Expired - Lifetime
- 2004-02-19 KR KR1020057016052A patent/KR20050115255A/ko not_active Application Discontinuation
- 2004-02-19 BR BRPI0407871-3A patent/BRPI0407871A/pt not_active IP Right Cessation
- 2004-02-19 CN CNB2004800054735A patent/CN100469761C/zh not_active Expired - Fee Related
- 2004-02-19 RU RU2005129998/04A patent/RU2005129998A/ru not_active Application Discontinuation
- 2004-02-19 JP JP2006501893A patent/JP2006519200A/ja active Pending
- 2004-02-19 WO PCT/EP2004/001587 patent/WO2004076401A1/de active Application Filing
- 2004-02-19 AT AT04712498T patent/ATE538086T1/de active
- 2004-02-19 MX MXPA05008990A patent/MXPA05008990A/es active IP Right Grant
- 2004-02-19 PL PL377755A patent/PL377755A1/pl not_active Application Discontinuation
- 2004-02-25 TW TW093104702A patent/TW200505830A/zh unknown
- 2004-02-27 PA PA20048596701A patent/PA8596701A1/es unknown
- 2004-02-27 PE PE2004000204A patent/PE20040958A1/es not_active Application Discontinuation
- 2004-02-27 AR ARP040100634A patent/AR043431A1/es not_active Application Discontinuation
-
2005
- 2005-07-19 ZA ZA200505766A patent/ZA200505766B/en unknown
- 2005-08-16 IL IL170315A patent/IL170315A/en not_active IP Right Cessation
- 2005-08-26 CO CO05085507A patent/CO5690544A2/es not_active Application Discontinuation
- 2005-08-26 MA MA28466A patent/MA27743A1/fr unknown
- 2005-08-26 HR HR20050739A patent/HRP20050739A2/xx not_active Application Discontinuation
- 2005-09-22 NO NO20054389A patent/NO20054389L/no unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA05008990A (es) | 2005-10-18 |
RU2005129998A (ru) | 2006-03-20 |
ATE538086T1 (de) | 2012-01-15 |
NO20054389D0 (no) | 2005-09-22 |
WO2004076401A1 (de) | 2004-09-10 |
CN100469761C (zh) | 2009-03-18 |
PE20040958A1 (es) | 2005-02-01 |
PA8596701A1 (es) | 2004-09-16 |
HRP20050739A2 (en) | 2006-08-31 |
CN1753865A (zh) | 2006-03-29 |
BRPI0407871A (pt) | 2006-03-01 |
CA2516633A1 (en) | 2004-09-10 |
MA27743A1 (fr) | 2006-02-01 |
EP1599443B1 (de) | 2011-12-21 |
EP1599443A1 (de) | 2005-11-30 |
NO20054389L (no) | 2005-11-03 |
AR043431A1 (es) | 2005-07-27 |
AU2004215678A1 (en) | 2004-09-10 |
TW200505830A (en) | 2005-02-16 |
ZA200505766B (en) | 2006-05-31 |
PL377755A1 (pl) | 2006-02-20 |
DE10308356A1 (de) | 2004-09-09 |
KR20050115255A (ko) | 2005-12-07 |
IL170315A (en) | 2010-11-30 |
JP2006519200A (ja) | 2006-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05009059A (es) | Derivados de heteroarilcarbamoilbenceno. | |
TW200510381A (en) | Novel 2-pyridinecarboxamide derivatives | |
AR058562A1 (es) | Derivados de pirimido [4,5 b] (1,4) oxazinas , procedimientos de obtencion y su uso como inhibidores de acetil coa y dgat 1 | |
CO6220952A2 (es) | Nuevos derivados de 3-([1,2,4]triazolo[4,3-a]piridin-7-il)benzamida | |
CO5690579A2 (es) | Derivados de diarilcicloalquilo, metodo para su produccion y su uso como medicamentos | |
NO20066015L (no) | Fuserte heterosykliske forbindelser | |
NO20076006L (no) | Acetylenderivater | |
PE20050444A1 (es) | Compuestos de piridina como inhibidores de la peptidasa | |
AR006720A1 (es) | Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende | |
DE602005023343D1 (de) | Pyrimidinderivate als gpcr-agonisten | |
ES2192520T3 (es) | Composicion farmaceutica. | |
AR066606A1 (es) | Compuestos de heteroarilamida pirimidona | |
CO5590960A2 (es) | Derivados de azaindolilalquilamina como ligandos de 5- hidroxitriptamina-6 | |
MX2009007954A (es) | Derivado de heterocicliden-n-(aril) acetamida. | |
CO5690544A2 (es) | Derivados de acido alcanoico sustituido con cicloalquilo metodos para su produccion y su uso como medicamentos | |
NO20072198L (no) | Korrosjons- og gasshydratinhibitorer med foroket biologisk nedbrytbarhet og redusert toksisitet | |
AR050250A1 (es) | Derivados de tetrahidroisoquinolilsulfonamidas, su preparacion y su utilizacion en terapeutica | |
AR070264A1 (es) | Derivados de oxazepinopirimidona heteroarilamida sustituidos | |
AR068115A1 (es) | Derivado del acido pirazolcarboxilico metodo de produccion del mismo y fungicida | |
MX2009012377A (es) | Compuestos de arilamida pirimidona. | |
AR066603A1 (es) | Derivados de arilamida pirimidona | |
CO5650235A2 (es) | Derivados de imidazol | |
AR042362A1 (es) | Derivados de 3h-quinazolin-4-ona, proceso de obtencion y composiciones farmaceuticas que los contienen | |
MXPA04009476A (es) | Compuestos de (tiazol-4,2-disustituidos-5-il)amina como inhibidores de la pde7. | |
MXPA05013631A (es) | Derivado heterociclico de metilsulfona. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |